Publications by authors named "T Behlendorf"

Claim this Profile
I
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial.
Petra Langerbeins, Sandra Robrecht, Pascal Nieper, Paula Cramer, Moritz Fürstenau, Timo Behlendorf

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO).
Sabrina Jotschke, Susann Schulze, Nadja Jaekel, Beatrice Ludwig-Kraus, Robby Engelmann, Timo Behlendorf

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.
Tobias Dechow, Ali Aldaoud, Timo Behlendorf, Wolfgang Knauf, Henning Eschenburg

Eur J Haematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic work-up for the detection of malnutrition in hospitalized cancer patients.
Camilla Leithold, Karin Jordan, Franziska Jahn, Timo Behlendorf, Judith Schaffrath

J Community Support Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Liposomal Cytarabine in the Treatment of Neoplastic Meningitis.
Franziska Jahn, Karin Jordan, Timo Behlendorf, Cordula Globig, Hans-Joachim Schmoll

Oncology· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis